Chargement en cours...
A comparative pharmacokinetic study of DRL_BZ, a candidate biosimilar of bevacizumab, with Avastin(®) (EU and US) in healthy male subjects
AIM: The aim of this study was to compare the pharmacokinetics (PK) of DRL_BZ with that of EU‐approved (reference medicinal product; RMP) and US‐licensed (reference product; RP) bevacizumab (Avastin(®)) in healthy male subjects. METHODS: In this double‐blind, parallel‐group, Phase 1 study (BZ‐01‐001...
Enregistré dans:
| Publié dans: | Br J Clin Pharmacol |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley and Sons Inc.
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6138499/ https://ncbi.nlm.nih.gov/pubmed/29943831 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.13691 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|